Moreover, some studies have identified that a novel factor named ribosomal protein S5 (RPS5) could regulate NF‐κB, MAPK and AKT signalling pathways,49, 50 which seems to be a promising target for osteoporosis treatment. This evidence concerns the gene AKT1 and osteoporosis.